oalib

Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99

Submit

Any time

2019 ( 1 )

2018 ( 2 )

2017 ( 3 )

2015 ( 10 )

Custom range...

Search Results: 1 - 10 of 307 matches for " Udbodh Bhandari "
All listed articles are free for downloading (OA Articles)
Page 1 /307
Display every page Item
Socio-Cultural and Economic Factors in Cross-Border Purchase: A Study of Customers’ Perspective in Sunauli-Nepal/India Border  [PDF]
Udaya Raj Paudel, Niranjan Devkota, Udbodh Bhandari
Modern Economy (ME) , 2018, DOI: 10.4236/me.2018.96070
Abstract:

Nepal and India sustain bilateral relationship and share social, cultural, economic, political and geographical proximities contributing people of both nations to a number of advantages. This study analyzes socio-cultural, geo-political, and economic proximities contributing people of Sunauli-India/Nepal border exploiting purposive sampling in 429 respondents with a structured questionnaire survey in February 2018. Descriptive and inferential data analysis techniques are performed along with Logistic Regression Model to interpret the determinants of cross-border purchase. The result revealed 96.3% of the total respondents involved in purchase, out of them, 85.6%, 77.2%, 71.6%, 71.2% and 54.6% purchase due to economical price of the goods, festivals, communication access, habit and open border factors respectively. The empirical results of the binary logistic regression models revealed different effects of the factors on customers cross border purchase. Economical goods (2.727***), hassle free cross-border imports (1.952***), language similarities (1.551**) and goods available in local market (1.268**) significantly and positively affect the cross-border purchasing activities and the Odds Ratio of given variables is 15.28, 7.04, 4.71 and 3.55 respectively. Following the analysis, the study concludes that there is positive influence of socio-cultural characteristics in cross border purchase. Open border factor is equally important to stimulate such purchasing activities. More than other factors, economic characteristics as availability of goods, their types and economical price are all in all important.

Disability: A Case Screening Program Approach  [PDF]
Sudarshan Paudel, Lilanath Bhandari, Dil Bahadur Bhandari
Journal of Biosciences and Medicines (JBM) , 2017, DOI: 10.4236/jbm.2017.52002
Abstract: Disability is an accident waiting to happen in population. Large numbers of population in world are disabled and its prevalence is on the rise. Disabled people have to face two additional challenges namely, limitation in body and social stigmatization on top of other social happening to general public. The stipulation of disability will be subjective because social and physical condition is directly related to it. The study was also envisioned to develop a disability screening approach. The objective was to focus on how disabled has been included in the government’s health plans in Nepal. The study has presented data of 894 disabled people from randomly selected seven VDCs of Makwanpur district. The total population in studied VDCs was 87,502. The study was conducted in coordination with local governing bodies and health development partners during August-October in 2012. The study revealed 1.02 percent prevalence of disability among study population. The majority were suffering physical disability (60.6 percent) followed by deaf (19.7 percent). Based on age group, young adults (15 - 19 years) group was more (31 percent) vulnerable. Out of total, the number of male was higher due to their high exposure in external environment and risk taking behaviour.
DEXRABEPRAZOLE: A NEW EMERGING APPORACH IN TREATMENT OF GIT DISORDER
Bhandari Aakanksha,Bhandari Monika,Bhandari Anil
International Research Journal of Pharmacy , 2011,
Abstract: Dexrabeprazole [R(+) rabeprazole] is a novel proton-pump inhibitor which is used in treatment of acid peptic diseases, gastroesophageal reflux disease (GERD) maintenance therapy, erosive esophagitis, short-term treatment of active duodenal and zollinger-ellison syndrome and treatment of H.Pylori-induced ulcers. This review explains superiority of dexrabeprazole (at half the recommended rabeprazole dose) over rabeprazole in terms of favourable pharmacokinetics, more efficacy, longer half-life, better healing of esophagitis, and fastly symptom control.
Stress and health related quality of life of Nepalese students studying in South Korea: A cross sectional study
Pratibha Bhandari
Health and Quality of Life Outcomes , 2012, DOI: 10.1186/1477-7525-10-26
Abstract: One hundred and thirty students were enrolled in this study. HRQOL was assessed using the Medical Outcomes Study Short Forms (SF-12) questionnaire. Perceived stress and acculturative stress was measured using the Perceived Stress Scale and Acculturative Stress Scale for international students, respectively. Pearson's correlation test and multiple regression analysis were performed.Perceived stress and acculturative stress were negatively correlated with HRQOL. The highest value in the HRQOL was reported for the vitality subscale and the lowest value was reported for the role-emotional. In the regression model, perceived stress, acculturative stress, relationship with advisor, and marital status accounted for a significant (p < .001) portion of the variance (49%) in the mental component summary of the HRQOL.The findings of this study indicate that Nepalese students studying in South Korea experience a considerable amount of perceived and acculturative stress, which is negatively related with their HRQOL. Provision of culture specific counseling and orientation programs may benefit the students. The determinants of HRQOL identified in this study were perceived stress, acculturative stress, relationship with advisor, and marital status.HRQOL is a multidimensional subjective concept and also an important health determinant [1]. Better HRQOL is vital for normal and productive functioning of an individual. Over the years, several studies have demonstrated the importance of HRQOL assessment among different groups of people, including university students. University life, where major life transition occurs, has often been recognized as a stressful period in one's life that can result in lowered levels of HRQOL. Academic pressures, peer pressure, pressures in relationships, being away from home, and financial concerns during the transition from school to university life have been identified as common stressors among university students [2]. Further in recent years following
Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice
Bhandari S
Therapeutics and Clinical Risk Management , 2011, DOI: http://dx.doi.org/10.2147/TCRM.S25882
Abstract: ate of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice Expert Opinion (2501) Total Article Views Authors: Bhandari S Published Date December 2011 Volume 2011:7 Pages 501 - 509 DOI: http://dx.doi.org/10.2147/TCRM.S25882 Sunil Bhandari Department of Renal Medicine, Hull and East Yorkshire Hospitals National Health Service Trust and Hull York Medical School, Kingston upon Hull, UK Background: The clinical need to be able to administer high doses of intravenous iron conveniently as a rapid infusion has been addressed by the recent introduction of ferric carboxymaltose and subsequently iron isomaltoside 1000. Neither requires a test dose. The maximum dose of ferric carboxymaltose is 1000 mg. The maximum dose of iron isomaltoside 1000 is based on 20 mg/kg body weight without a specified ceiling dose, thereby increasing the scope of being able to achieve total iron repletion with a single infusion. This ability to give high doses of iron is important in the context of managing iron deficiency anemia, which is associated with a number of clinical conditions where demands for iron are high. It is also an important component of the strategy as an alternative to blood transfusion. Affordability is a key issue for health services. Recent price changes affecting iron sucrose and ferric carboxymaltose, plus modifications to the manufacturers’ prescribing information, have provoked this update. Methods: This study is a comparative analysis of the costs of acquiring and administering the newly available intravenous iron formulations against standard treatments in the hospital setting. The costs include the medication, nursing costs, equipment, and patient transportation. Three dosage levels (600 mg, 1000 mg, and 1600 mg) are considered. Results and conclusion: The traditional standard treatments, blood and iron sucrose, cost more than the alternative intravenous iron preparations across the dose spectrum and sensitivities. Low molecular weight iron dextran is the least expensive option at the 1600 mg dose level but has the caveat of a prolonged administration time and requirement for a test dose. At 600 mg and 1000 mg dose levels, both iron isomaltoside 1000 and ferric carboxymaltose are more economical than low molecular weight iron dextran. Iron isomaltoside 1000 is less expensive than ferric carboxymaltose at all dose levels. Newly available iron preparations appear to be clinically promising, cost effective, and practical alternatives to current standards of iron repletion.
A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000
Sunil Bhandari
Therapeutics and Clinical Risk Management , 2011, DOI: http://dx.doi.org/10.2147/TCRM.S17536
Abstract: hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000 Perspectives (3920) Total Article Views Authors: Sunil Bhandari Published Date March 2011 Volume 2011:7 Pages 103 - 113 DOI: http://dx.doi.org/10.2147/TCRM.S17536 Sunil Bhandari Department of Renal Medicine, Hull and East Yorkshire Hospitals National Health Service Trust and Hull York Medical School, Kingston upon Hull, UK Background: The clinical need to be able to administer high doses of intravenous iron conveniently in a single rapid infusion has been addressed by the recent introduction of ferric carboxymaltose and subsequently iron isomaltoside 1000. Neither requires a test dose. Ferric carboxymaltose can be administered at 15 mg/kg body weight to a maximum dose of 1000 mg, whereas iron isomaltoside 1000 can be administered at 20 mg/kg body weight. The ability to give high doses of iron is important in the context of managing iron deficiency anemia in a number of clinical conditions where demands for iron are high (including chronic blood loss associated with inflammatory bowel disease, menorrhagia, and chronic kidney disease). It is also an important component in the strategy as an alternative to a blood transfusion. Affordability is a key issue for health services. Methods: This study was a comparative analysis of the costs of administering the newly available intravenous iron formulations against standard practice (blood transfusion, intravenous iron sucrose) by considering the cost of this treatment option plus nursing costs associated with administration, equipment for administration, and patient transportation in the secondary care (hospital) setting across three dosage levels (600 mg, 1000 mg, and 1600 mg). Results and conclusion: The analysis indicates that the use of iron isomaltoside 1000 results in a net saving when compared with iron sucrose, blood, and ferric carboxymaltose. At 600 mg and 1000 mg doses, it is cheaper than low-molecular-weight iron dextran but more expensive at a dose of 1600 mg. However, it takes six hours to administer low-molecular-weight iron dextran at this dose level, which is inconvenient and reduces patient throughput (productivity).
Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice
Bhandari S
Therapeutics and Clinical Risk Management , 2011,
Abstract: Sunil BhandariDepartment of Renal Medicine, Hull and East Yorkshire Hospitals National Health Service Trust and Hull York Medical School, Kingston upon Hull, UKBackground: The clinical need to be able to administer high doses of intravenous iron conveniently as a rapid infusion has been addressed by the recent introduction of ferric carboxymaltose and subsequently iron isomaltoside 1000. Neither requires a test dose. The maximum dose of ferric carboxymaltose is 1000 mg. The maximum dose of iron isomaltoside 1000 is based on 20 mg/kg body weight without a specified ceiling dose, thereby increasing the scope of being able to achieve total iron repletion with a single infusion. This ability to give high doses of iron is important in the context of managing iron deficiency anemia, which is associated with a number of clinical conditions where demands for iron are high. It is also an important component of the strategy as an alternative to blood transfusion. Affordability is a key issue for health services. Recent price changes affecting iron sucrose and ferric carboxymaltose, plus modifications to the manufacturers’ prescribing information, have provoked this update.Methods: This study is a comparative analysis of the costs of acquiring and administering the newly available intravenous iron formulations against standard treatments in the hospital setting. The costs include the medication, nursing costs, equipment, and patient transportation. Three dosage levels (600 mg, 1000 mg, and 1600 mg) are considered.Results and conclusion: The traditional standard treatments, blood and iron sucrose, cost more than the alternative intravenous iron preparations across the dose spectrum and sensitivities. Low molecular weight iron dextran is the least expensive option at the 1600 mg dose level but has the caveat of a prolonged administration time and requirement for a test dose. At 600 mg and 1000 mg dose levels, both iron isomaltoside 1000 and ferric carboxymaltose are more economical than low molecular weight iron dextran. Iron isomaltoside 1000 is less expensive than ferric carboxymaltose at all dose levels. Newly available iron preparations appear to be clinically promising, cost effective, and practical alternatives to current standards of iron repletion.Keywords: iron isomaltoside 1000, ferric carboxymaltose, iron deficiency anemia, single high dose, IV iron, cost minimization
A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000
Sunil Bhandari
Therapeutics and Clinical Risk Management , 2011,
Abstract: Sunil BhandariDepartment of Renal Medicine, Hull and East Yorkshire Hospitals National Health Service Trust and Hull York Medical School, Kingston upon Hull, UKBackground: The clinical need to be able to administer high doses of intravenous iron conveniently in a single rapid infusion has been addressed by the recent introduction of ferric carboxymaltose and subsequently iron isomaltoside 1000. Neither requires a test dose. Ferric carboxymaltose can be administered at 15 mg/kg body weight to a maximum dose of 1000 mg, whereas iron isomaltoside 1000 can be administered at 20 mg/kg body weight. The ability to give high doses of iron is important in the context of managing iron deficiency anemia in a number of clinical conditions where demands for iron are high (including chronic blood loss associated with inflammatory bowel disease, menorrhagia, and chronic kidney disease). It is also an important component in the strategy as an alternative to a blood transfusion. Affordability is a key issue for health services.Methods: This study was a comparative analysis of the costs of administering the newly available intravenous iron formulations against standard practice (blood transfusion, intravenous iron sucrose) by considering the cost of this treatment option plus nursing costs associated with administration, equipment for administration, and patient transportation in the secondary care (hospital) setting across three dosage levels (600 mg, 1000 mg, and 1600 mg).Results and conclusion: The analysis indicates that the use of iron isomaltoside 1000 results in a net saving when compared with iron sucrose, blood, and ferric carboxymaltose. At 600 mg and 1000 mg doses, it is cheaper than low-molecular-weight iron dextran but more expensive at a dose of 1600 mg. However, it takes six hours to administer low-molecular-weight iron dextran at this dose level, which is inconvenient and reduces patient throughput (productivity).Keywords: iron isomaltoside 1000, iron deficiency anemia, high dose, single dose, parenteral iron, cost minimization
Total hip arthroplasty or hemi-arthroplasty for displaced femoral neck fractures
Bhandari Mohit
Indian Journal of Orthopaedics , 2011,
Abstract:
Estimation of Potential Evapotranspiration and Crop Coefficient of Wheat at Rupandehi District of Nepal
Govinda Bhandari
International Journal of Agricultural Management and Development , 2012,
Abstract: This study is carried out to estimate the potential evapotranspiration (PET) and crop coefficient (Kc) for Wheat, BL3235 variety. A lysimeter is installed to estimate PET at the experimental farm of Agricultural Research Center of Bhairahawa,which is located in western part of Nepal. The Blaney-Criddleformula is used to estimate the Kc for wheat. The estimatedvalues of PET and Kc for wheat at the four crop growth stages(initial, crop development, mid season/reproductive and lateseason/maturity) are 3.5 cm, 7.82 cm, 11.3 cm, 1.16 cm and0.34, 0.67, 0.73, 0.06 respectively. The total value of PET andaverage value of Kc for Wheat is 23.78 cm and 0.45. Aridityindex (AI), the ratio of precipitation to PET, is an important parameter to determine the dryness of a region. The average valueof AI at the Wheat growing season (January to April, 2011) inBhairahawa is 0.39, and is classified as a semiarid region.
Page 1 /307
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.